Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.42
|
2.60
|
2.44
|
2.44
|
2.55
|
2.53
|
|
|
13 106.84
|
92.00
|
2.31
|
2.63
|
2.40
|
2.39
|
2.46
|
2.39
|
|
|
9 279.61
|
63.00
|
2.33
|
2.45
|
2.39
|
2.37
|
2.44
|
2.41
|
|
|
6 961.14
|
73.00
|
2.32
|
2.45
|
2.34
|
2.34
|
2.44
|
2.375
|
|
|
18 591.22
|
166.00
|
2.26
|
2.44
|
2.30
|
2.22
|
2.37
|
2.325
|
|
|
19 729.87
|
173.00
|
2.29
|
2.40
|
2.40
|
2.28
|
2.40
|
2.28
|
|
|
23 448.76
|
173.00
|
2.37
|
2.49
|
2.40
|
2.40
|
2.42
|
2.41
|
|
|
4 586.54
|
48.00
|
2.36
|
2.63
|
2.36
|
2.35
|
2.41
|
2.38
|
|
|
6 351.26
|
93.00
|
2.30
|
2.63
|
2.47
|
2.365
|
2.47
|
2.365
|
|
|
22 977.86
|
171.00
|
2.39
|
2.50
|
2.44
|
2.40
|
2.47
|
2.465
|
|
|
15 544.19
|
86.00
|
AN2 Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. AN2 Therapeutics serves customers worldwide.